Immune function modulating agents
US-9314041-B2 · Apr 19, 2016 · US
Lactobacillus plantarum and composition comprising same
US10842833B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10842833-B2 |
| Application number | US-201816148569-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 1, 2018 |
| Priority date | Jul 22, 2009 |
| Publication date | Nov 24, 2020 |
| Grant date | Nov 24, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides Lactobacillus plantarum CJLP133 KCTC 11403BP, a composition for treating intestinal diseases comprising the lactic acid bacteria, and a composition for enhancing immunity comprising the lactic acid bacteria.
First claim
Opening claim text (preview).
What is claims is: 1. A method for improving a microbial environment in a gastrointestinal tract of a subject, comprising: administering a composition comprising Lactobacillus plantarum CJLP133 strain KCTC 11403BP to the subject in need thereof. 2. The method of claim 1 , wherein the composition is selected from the group consisting of pharmaceuticals, food, animal feed, feed additives and cosmetics. 3. The method of claim 1 , wherein the subject is a human. 4. The method of claim 1 , wherein the composition is administered orally.
Assignees
Inventors
Classifications
Lactobacillus · CPC title
- A23K10/18Primary
of live microorganisms · CPC title
Lactobacillus plantarum · CPC title
Bacterial isolates · CPC title
Preparations for care of the skin · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10842833B2 cover?
- The present invention provides Lactobacillus plantarum CJLP133 KCTC 11403BP, a composition for treating intestinal diseases comprising the lactic acid bacteria, and a composition for enhancing immunity comprising the lactic acid bacteria.
- Who is the assignee on this patent?
- Cj Cheiljedang Corp
- What technology area does this patent fall under?
- Primary CPC classification A23K10/18. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).